Step 1
Draft
Step 2
Unite with Fellow Investors
Step 3
Choose the Best Attorney
Step 4
Provide Documents
Step 5
Follow Case Progress
Step 6
Get Payout
AXSM.US
id: 1736
Axsome Therapeutics ($AXSM) $7.75M Investor Settlement
Late claims are being considered for compensation, subject to approval.
$7,750,000
Cash SettlementS.D. New York
Court1:22-cv-03925
Case number05/10/2021
Class period Start04/22/2022
Class period End02/03/2026
Claim deadlineAxsome Therapeutics has agreed to a $7.75 million settlement with $AXSM investors to resolve claims that it misled them about regulatory risks related to the company’s migraine drug AXS-07.
Case Type
US Securities Class Action
Case Status
Accepting Late Claims
Alleged Offence
Misleading Statements,
Financial Misrepresentation,
Failure to Disclose
Suspected Party
Management
Security Type
Stocks
Trade Direction
Long
Payout per Share
0.46
Filing date
05/13/2022
Plaintiffs
Evy Gru
Attorneys
Pomerantz LLP
Defendants
Herriot Tabuteau; Nick Pizzie; Mark Jacobson; Cedric O’Gorman
Administrator
Strategic Claims Services
Court hearing date
02/10/2026
Exclusion deadline
01/13/2026
Objection deadline
01/13/2026
Attorney fee
$2,733,333
Trades matching type
FIFO
Frequently Asked Questions
Who is eligible for this settlement?
Do I have to sell securities to be eligible?
How long does the payout process take?
How to get your payout?
What is 11th.com?
Trusted by industry leaders
Endorsed by top professionals who trust our innovative solutions to drive impactful results.